Cardiff Oncology (CRDF) Gross Profit (2014 - 2019)
Cardiff Oncology (CRDF) posted Gross Profit of $94072.0 for Q4 2019, up 82.0% sequentially from $51687.0 in Q3 2019, and up 20.58% YoY from $78015.0 in Q4 2018.
Cardiff Oncology (CRDF) Gross Profit (2014 - 2019) Analysis & Trends
Cardiff Oncology has reported Gross Profit for 6 years, with the latest figure at $94072.0 in Q4 2019.
- Quarterly Gross Profit rose 20.58% year-over-year to $94072.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $244632.0 (up 190.53% YoY) and the FY2019 annual result came in at $244632.0, up 211.64% from the prior year.
- Gross Profit improved to $94072.0 in Q4 2019 per CRDF's latest filing, from $51687.0 in the prior quarter.
- Over five years, Gross Profit peaked at $94072.0 in Q4 2019 and troughed at -$550600.0 in Q1 2017.
- A 5-year average of -$154554.6 and a median of -$117868.0 in 2015 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2016 and 2019: Gross Profit tumbled 884.41% in 2016, then soared 139.79% in 2019.
- Over 5 years, Gross Profit stood at -$120199.0 in 2015, then slumped by 331.97% to -$519219.0 in 2016, then jumped by 61.75% to -$198593.0 in 2017, then surged by 139.28% to $78015.0 in 2018, then increased by 20.58% to $94072.0 in 2019.
- According to Business Quant data, Gross Profit over the past three periods registered $94072.0, $51687.0, and $36852.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 94,072.00 |
| Dec 31, 2019 | 94,072.00 |
| Sep 30, 2019 | 51,687.00 |
| Sep 30, 2019 | 51,687.00 |
| Jun 30, 2019 | 36,852.00 |
| Jun 30, 2019 | 36,852.00 |
| Mar 31, 2019 | 62,021.00 |
| Mar 31, 2019 | 62,021.00 |
| Dec 31, 2018 | 78,015.00 |
| Dec 31, 2018 | 78,015.00 |
| Sep 30, 2018 | 61,684.00 |
| Sep 30, 2018 | 61,684.00 |
| Jun 30, 2018 | -92,623.00 |
| Jun 30, 2018 | -92,623.00 |
| Mar 31, 2018 | -317,289.00 |
| Mar 31, 2018 | -317,289.00 |
| Dec 31, 2017 | -198,593.00 |
| Dec 31, 2017 | -198,593.00 |
| Sep 30, 2017 | -414,423.00 |
| Sep 30, 2017 | -414,423.00 |